Your session is about to expire
← Back to Search
radiation therapy for Gastric Adenocarcinoma
Study Summary
This trial is testing a new combination of drugs to treat cancer of the esophagus, and will compare it to the standard of care.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My cancer diagnosis is specifically adenocarcinoma.My cancer is a type of adenocarcinoma located in my esophagus, GEJ, or stomach.I do not have any active cancer except for certain skin, cervical, prostate, or non-invasive breast cancers.I had treatment for prostate cancer aimed at curing it, and my PSA levels are now normal or undetectable.I will use effective birth control during and for 3 months after the study.I do not have severe numbness or pain in my hands or feet.My cancer is not classified as T4b (unresectable) or M1 (spread to distant areas).I do not have angina, heart failure with an ejection fraction below 50%, or ischemic heart disease.I do not have a history of hepatitis B or C.My cancer is at a specific stage and has been confirmed with certain tests.I do not have any current infections.My kidney function is within the required range for the study.I have Gilbert's syndrome but my total bilirubin is ≤ 3 and my liver tests are normal.I am fully active or restricted in physically strenuous activity but can do light work.I haven't had chemo, radiation, or surgery for my cancer, but minor procedures are okay.
- Group 1: Positive Pathologic Response
- Group 2: Negative Pathologic Response
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many people suffering from this illness will be given the chance to try this new treatment?
"Currently, this clinical trial is not open for patient recruitment. The study was first posted on February 10th, 2014 with the latest update being July 25th, 2022. If you are interested in other trials, 994 studies involving stage iiia esophageal cancer and 1691 radiation therapy trials are actively recruiting patients."
Could you please explain the risks associated with radiation treatments?
"While there is some evidence backing radiation therapy's safety, as this is only a Phase 2 trial, it receives a score of 2."
Do you know of any other research that has looked at using radiation to treat patients?
"As of right now, there are 1691 on-going clinical trials researching radiation therapy. This includes 510 Phase 3 trials. The majority of these trials for radiation therapy are taking place in Guangzhou, Guangdong. However, there are a total of 88123 locations running studies related to this topic."
Are there any opportunities for volunteers in this research?
"Presently, this trial is not enrolling patients. The listing was first made on February 10th, 2014 and updated as recently as July 25th, 2022. If you are looking for other stage iiia esophageal cancer studies, 994 trials are recruiting patients while 1691 research projects are actively searching for radiation therapy participants."
What are some of the most frequent indications for radiation therapy?
"malignant neoplasms is often managed through radiation therapy. This same treatment can also help with other afflictions like rectal carcinoma, advanced gastric cancer, and conditioning regimens for allogeneic stem cell transplantation therapy."
Share this study with friends
Copy Link
Messenger